The R278I Mutation of in the Familial Alzheimer Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Dillen K, Annaert W
. A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: are we progressing toward therapy?. Int Rev Cytol. 2006; 254:215-300.
DOI: 10.1016/S0074-7696(06)54005-7.
View
2.
Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania F, Mitra R
. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One. 2012; 7(2):e31039.
PMC: 3270040.
DOI: 10.1371/journal.pone.0031039.
View
3.
Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T
. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91.
PMC: 5018207.
DOI: 10.1038/nature19057.
View
4.
Nicolas G, Wallon D, Charbonnier C, Quenez O, Rousseau S, Richard A
. Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons. Eur J Hum Genet. 2015; 24(5):710-6.
PMC: 4930083.
DOI: 10.1038/ejhg.2015.173.
View
5.
Ryan N, Biessels G, Kim L, Nicholas J, Barber P, Walsh P
. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease. Neurobiol Aging. 2015; 36(12):3140-3151.
DOI: 10.1016/j.neurobiolaging.2015.08.026.
View